Story
UnitedHealth Stock Surges After Crushing Q2 Earnings, Raising Full-Year Guidance

Summary
The healthcare giant's shares soared after it reported a significant beat on second-quarter profit and revenue, driven by a key improvement in its medical cost ratio, and boosted its 2026 earnings forecast.
UnitedHealth Group (NYSE: UNH) shares surged more than 7% in pre-market trading after the health insurance and services giant reported second-quarter results that far surpassed analyst expectations and raised its full-year profit forecast, signaling a significant improvement in medical cost trends.
Earnings Beat and Cost Control
UnitedHealth posted adjusted earnings of $6.38 per share for the second quarter of 2026, easily beating the Wall Street consensus of around $4.85, according to Investing.com. Revenue for the quarter came in at $112.0 billion, also topping the $110.76 billion estimate.
A critical metric for investors, the medical care ratio (MCR), showed substantial improvement. The MCR, which represents the share of premium revenue paid out for medical claims, fell to 86.7% from 89.4% a year earlier. This figure was significantly better than the 88.6% analysts had anticipated, easing a central concern for shareholders about rising healthcare costs.
Upgraded Outlook and Market Reaction
Buoyed by the strong results and citing robust performance in its Optum segment, the company raised its full-year 2026 adjusted earnings per share guidance to a range of $19.50 to $20.00. This new forecast is well above the analyst consensus of approximately $18.48.
AdInvestors reacted enthusiastically to the comprehensive beat-and-raise report. The stock jumped 7.6% in pre-open trading to $450.55, eclipsing its prior 52-week high. The strong company-specific performance came against a mixed backdrop for the broader U.S. market.
Context for the Rally
The blowout results effectively reversed negative sentiment that had weighed on the managed care sector. UnitedHealth's stock had dipped in the previous session following a report from peer Elevance Health that highlighted persistent margin pressures in the Medicaid business.
UnitedHealth's report, demonstrating strong cost management and a confident outlook, appears to have convinced the market that its operational turnaround has gained decisive traction.
Read next
More on Stocks
Volvo Cars Appoints Klaus Zellmer as Next CEO to Succeed Hakan Samuelsson
Volvo Cars has named Klaus Zellmer as its next president and chief executive officer, replacing the departing Hakan Samuelsson. The transition comes as the automaker pursues an aggressive growth strategy amid market challenges.

Analyst 'Strong Buy' Ratings Signal Upside for TSX-Listed Miners
Several Canadian gold and copper miners, including Equinox Gold and Kinross Gold, are attracting strong buy ratings from analysts who project double-digit upside potential based on recent company-specific catalysts.

Saudi Tadawul All Share Index Slips to 1-Month Low on Broad Sector Declines
Saudi Arabia's benchmark stock index, the Tadawul All Share, closed down 0.26% on Sunday to reach its lowest point in a month, dragged lower by weakness in the insurance and energy sectors.

Higher Yields, Slowing Earnings, and IPOs Pose Key Risks to Stock Valuations, BCA Says
Analysts at BCA Research warn that rising bond yields, moderating earnings growth, and heavy IPO issuance are significant risks to stock valuations. They maintain a constructive outlook but stress that future market gains will depend more on earnings strength than P/E expansion.